vs

Side-by-side financial comparison of Penumbra Inc (PEN) and PROVIDENT FINANCIAL SERVICES INC (PFS). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $225.2M, roughly 1.7× PROVIDENT FINANCIAL SERVICES INC). PROVIDENT FINANCIAL SERVICES INC runs the higher net margin — 35.3% vs 12.3%, a 23.0% gap on every dollar of revenue. Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs 17.3%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

The PNC Financial Services Group, Inc. is an American bank holding company and financial services corporation based in Pittsburgh, Pennsylvania. Its banking subsidiary, PNC Bank, operates in 27 states and the District of Columbia, with 2,629 branches and 9,523 ATMs. PNC Bank is one of the largest banks in the US by assets and by number of branches, deposits, and ATMs.

PEN vs PFS — Head-to-Head

Bigger by revenue
PEN
PEN
1.7× larger
PEN
$385.4M
$225.2M
PFS
Higher net margin
PFS
PFS
23.0% more per $
PFS
35.3%
12.3%
PEN
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
17.3%
PFS

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PEN
PEN
PFS
PFS
Revenue
$385.4M
$225.2M
Net Profit
$47.3M
$79.4M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
12.3%
35.3%
Revenue YoY
22.1%
Net Profit YoY
40.6%
24.0%
EPS (diluted)
$1.20
$0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
PFS
PFS
Q1 26
$225.2M
Q4 25
$385.4M
$225.7M
Q3 25
$354.7M
$221.8M
Q2 25
$339.5M
$214.2M
Q1 25
$324.1M
$208.8M
Q4 24
$315.5M
$205.9M
Q3 24
$301.0M
$210.6M
Q2 24
$299.4M
$163.8M
Net Profit
PEN
PEN
PFS
PFS
Q1 26
$79.4M
Q4 25
$47.3M
Q3 25
$45.9M
$71.7M
Q2 25
$45.3M
$72.0M
Q1 25
$39.2M
$64.0M
Q4 24
$33.7M
Q3 24
$29.5M
$46.4M
Q2 24
$-60.2M
$-11.5M
Gross Margin
PEN
PEN
PFS
PFS
Q1 26
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Operating Margin
PEN
PEN
PFS
PFS
Q1 26
Q4 25
15.4%
49.7%
Q3 25
13.8%
45.8%
Q2 25
12.0%
47.8%
Q1 25
12.4%
44.0%
Q4 24
13.6%
30.5%
Q3 24
11.7%
31.0%
Q2 24
-27.0%
-13.0%
Net Margin
PEN
PEN
PFS
PFS
Q1 26
35.3%
Q4 25
12.3%
Q3 25
12.9%
32.3%
Q2 25
13.3%
33.6%
Q1 25
12.1%
30.7%
Q4 24
10.7%
Q3 24
9.8%
22.0%
Q2 24
-20.1%
-7.0%
EPS (diluted)
PEN
PEN
PFS
PFS
Q1 26
$0.61
Q4 25
$1.20
$0.64
Q3 25
$1.17
$0.55
Q2 25
$1.15
$0.55
Q1 25
$1.00
$0.49
Q4 24
$0.88
$0.37
Q3 24
$0.75
$0.36
Q2 24
$-1.55
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
PFS
PFS
Cash + ST InvestmentsLiquidity on hand
$186.9M
$222.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$2.9B
Total Assets
$1.8B
$25.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
PFS
PFS
Q1 26
$222.1M
Q4 25
$186.9M
$209.1M
Q3 25
$321.0M
$299.2M
Q2 25
$421.8M
$258.0M
Q1 25
$376.1M
$234.1M
Q4 24
$324.4M
$205.9M
Q3 24
$280.5M
$244.0M
Q2 24
$288.3M
$290.5M
Stockholders' Equity
PEN
PEN
PFS
PFS
Q1 26
$2.9B
Q4 25
$1.4B
$2.8B
Q3 25
$1.4B
$2.8B
Q2 25
$1.3B
$2.7B
Q1 25
$1.2B
$2.7B
Q4 24
$1.2B
$2.6B
Q3 24
$1.1B
$2.6B
Q2 24
$1.2B
$2.6B
Total Assets
PEN
PEN
PFS
PFS
Q1 26
$25.2B
Q4 25
$1.8B
$25.0B
Q3 25
$1.7B
$24.8B
Q2 25
$1.7B
$24.5B
Q1 25
$1.6B
$24.2B
Q4 24
$1.5B
$24.1B
Q3 24
$1.5B
$24.0B
Q2 24
$1.5B
$24.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
PFS
PFS
Operating Cash FlowLast quarter
$86.5M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
PFS
PFS
Q1 26
Q4 25
$86.5M
$442.3M
Q3 25
$58.3M
$98.0M
Q2 25
$44.9M
$186.8M
Q1 25
$49.0M
$88.5M
Q4 24
$51.1M
$426.4M
Q3 24
$56.5M
$69.2M
Q2 24
$22.6M
$76.5M
Free Cash Flow
PEN
PEN
PFS
PFS
Q1 26
Q4 25
$68.0M
$430.7M
Q3 25
$42.0M
$96.7M
Q2 25
$29.4M
$182.6M
Q1 25
$35.5M
$87.4M
Q4 24
$45.7M
$425.1M
Q3 24
$51.0M
$67.9M
Q2 24
$18.1M
$75.5M
FCF Margin
PEN
PEN
PFS
PFS
Q1 26
Q4 25
17.7%
190.8%
Q3 25
11.8%
43.6%
Q2 25
8.7%
85.2%
Q1 25
11.0%
41.9%
Q4 24
14.5%
206.4%
Q3 24
16.9%
32.2%
Q2 24
6.0%
46.1%
Capex Intensity
PEN
PEN
PFS
PFS
Q1 26
Q4 25
4.8%
5.1%
Q3 25
4.6%
0.6%
Q2 25
4.6%
2.0%
Q1 25
4.2%
0.5%
Q4 24
1.7%
0.6%
Q3 24
1.8%
0.6%
Q2 24
1.5%
0.6%
Cash Conversion
PEN
PEN
PFS
PFS
Q1 26
Q4 25
1.83×
Q3 25
1.27×
1.37×
Q2 25
0.99×
2.59×
Q1 25
1.25×
1.38×
Q4 24
1.52×
Q3 24
1.91×
1.49×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

PFS
PFS

Net Interest Income$193.7M86%
Noninterest Income$31.5M14%

Related Comparisons